A novel method for downstream characterization of breast cancer circulating tumor cells following CellSearch isolation.

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskriftPeer review

18 Citeringar (SciVal)
216 Nedladdningar (Pure)

Sammanfattning

Enumeration of circulating tumor cells (CTCs) obtained from minimally invasive blood samples has been well established as a valuable monitoring tool in metastatic and early breast cancer, as well as in several other cancer types. The gold standard technology for detecting CTCs in blood against a backdrop of millions of leukocytes is the FDA-approved CellSearch system (Janssen Diagnostics), which relies on EpCAM-based immunomagnetic separation. Secondary characterization of these cells could enable treatment selection based on specific targets in these cells, as well as providing a real time window into the metastatic process and offering unique insights into tumor heterogeneity. The objective of this study was to develop a method for downstream characterization of CTCs following isolation with the CellSearch system.
Originalspråkengelska
Artikelnummer126
TidskriftJournal of Translational Medicine
Volym13
Utgåva1
DOI
StatusPublished - 2015

Ämnesklassifikation (UKÄ)

  • Cancer och onkologi

Fingeravtryck

Utforska forskningsämnen för ”A novel method for downstream characterization of breast cancer circulating tumor cells following CellSearch isolation.”. Tillsammans bildar de ett unikt fingeravtryck.

Citera det här